Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gilead Sciences Inc buy Morgan Stanley

Start price
€87.65
10.01.25 / 50%
Target price
€110.16
10.01.26
Performance (%)
21.83%
Price
€103.62
18.12.25
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 21.83%. Dividends of €3.16 are taken into consideration when calculating the performance. This prediction currently runs until 10.01.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Gilead Sciences Inc -1.277% -1.277%
iShares Core DAX® -0.793% 4.201%
iShares Nasdaq 100 -2.376% 0.857%
iShares Nikkei 225® -2.701% -0.147%
iShares S&P 500 -1.689% 1.244%

Comments by Morgan_Stanley for this prediction

In the thread Gilead Sciences Inc diskutieren
Prediction Buy
Perf. (%) 21.83%
Target price 110.164
Change
Ends at 10.01.26

Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $113.00 price target on the stock, up previously from $87.00.
Ratings data for GILD provided by MarketBeat

Stopped prediction by Morgan_Stanley for Gilead Sciences Inc

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€104.14
12.12.25
€128.70
12.12.26
0.26%
18.12.25

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€105.14
31.10.25
€127.04
31.10.26
-0.69%
18.12.25

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€91.07
25.04.25
€118.99
25.04.26
16.38%
18.12.25

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€105.60
11.03.25
€119.76
11.03.26
1.12%
18.12.25